UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
|
|
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): March 17, 2010 (March 16, 2010)
|
|
|
Ampal-American Israel Corporation
(Exact name of registrant as specified in its charter)
|
New York
|
0-538
|
13-0435685
|
|
|
555 Madison Avenue
|
|
||
|
(866) 447-8636
|
|||
|
|
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
|
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
|
Item 7.01 |
Regulation FD Disclosure . |
On March 16, 2010, Ampal-American Israel Corporation (the Company) issued a press release announcing that Midroog Ltd. (an affiliate of Moodys Investors Service) has removed the Companys Series A and Series B debentures (Debentures) from its Watchlist. The rating of the Debentures remains A3 and receives a negative outlook.
The full text of the press release is attached to this Current Report as Exhibit 99.1 and is incorporated herein by reference.
In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
|
Item 9.01 |
Financial Statements and Exhibits . |
(d) Exhibits:
|
EXHIBIT |
DESCRIPTION |
|
99.1 |
Press release of Ampal-American Israel Corporation, dated March 16, 2010. |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
AMPAL-AMERICAN ISRAEL CORPORATION |
|
|
|
|
|
|
Date: March 17, 2010 |
By: |
/s/ Yoram Firon |
|
|
|
Name: Yoram Firon |
|
|
|
Title:
Vice President - Investments and
|
3
EXHIBIT INDEX
|
EXHIBIT |
DESCRIPTION |
|
99.1 |
Press release of Ampal-American Israel Corporation, dated March 16, 2010. |
Exhibit 99.1
|
FOR: |
AMPAL-AMERICAN ISRAEL CORPORATION |
|
CONTACT: |
Irit Eluz |
|
|
CFO - SVP Finance & Treasurer |
|
|
1 866 447 8636 |
|
|
irit@ampal.com |
|
|
|
|
FOR: |
KM/KCSA - Investor Relations |
|
CONTACT: |
Roni Gavrielov |
|
|
011-972-3-516-7620 |
|
|
roni@km-ir.co.il |
|
|
|
|
|
Jeff Corbin / Marybeth Csaby |
|
|
212-896-1214 / 212-896-1236 |
|
|
jcorbin@kcsa.com / mcsaby@kcsa.com |
|
|
|
|
FOR: |
PM-PR Media consultants |
|
CONTACT: |
Zeev Feiner |
|
|
011-972-50-790-7890 |
|
|
z@pm-pr.com |
AMPAL-AMERICAN ISRAEL CORPORATION ISRAELI DEBENTURES THAT ARE RATED A3 BY MIDROOG ARE REMOVED FROM THE WATCHLIST AND RECEIVES A NEGATIVE OUTLOOK
Tel Aviv, Israel March 16, 2010 Ampal-American Israel Corporation (NASDAQ: "AMPL") announced today that Midroog Ltd. (an affiliate of Moody's Investors Service) ("Midroog") has removed Ampal's Series A and Series B Debentures ("Debentures") from its "Watchlist. The rating of the Debentures remains A3 and receives a negative outlook.
About Ampal:
Ampal and its subsidiaries acquire interests primarily in businesses located in the State of Israel or that are Israel-related. Ampal is seeking opportunistic situations in a variety of industries, with a focus on energy, chemicals, communication and related sectors. Ampals goal is to develop or acquire majority interests in businesses that are profitable and generate significant free cash flow that Ampal can control. For more information about Ampal please visit our web site at www.ampal.com.
Certain information in this press release includes forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934) and information relating to Ampal that are based on the beliefs of management of Ampal as well as assumptions made by and information currently available to the management of Ampal. When used in this press release, the words "anticipate," "believe," "estimate," "expect," "intend," "plan," and similar expressions as they relate to Ampal or Ampal's management, identify forward-looking statements. Such statements reflect the current views of Ampal with respect to future events or future financial performance of Ampal, the outcome of which is subject to certain risks and other factors which could cause actual results to differ materially from those anticipated by the forward-looking statements, including among others, the economic and political conditions in Israel, the Middle East, including the situation in Iraq, and the global business and economic conditions in the different sectors and markets where Ampal's portfolio companies operate. Should any of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results or outcome may vary from those described herein as anticipated, believed, estimated, expected, intended or planned. Subsequent written and oral forward-looking statements attributable to Ampal or persons acting on its behalf are expressly qualified in their entirety by the cautionary statements in this paragraph. Please refer to the Ampal's annual, quarterly and periodic reports on file with the SEC for a more detailed discussion of these and other risks that could cause results to differ materially. Ampal assumes no obligation to update or revise any forward-looking statements.